SCHEMBL7307946

SCHEMBL7307946

COC(=O)CCc1c(O)nc(OC)c2cc(OC)c(OC)cc12

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 1/20 0.54
PDE3A Q14432 1/20 0.54
KDM4E B2RXH2 2/20 0.43
BACE1 P56817 1/20 0.37
HMGCR P04035 2/20 0.37
EGFR P00533 1/20 0.35
SRC P12931 1/20 0.35
TNF P01375 1/20 0.35
PDE4D Q08499 2/20 0.35
TSHR P16473 1/20 0.34
PDE10A Q9Y233 1/20 0.33
ALOX5 P09917 1/20 0.33
OR51E2 Q9H255 1/20 0.33
RPS6KB2 Q9UBS0 1/20 0.33
GABRA1 P14867 1/20 0.33
GABRA5 P31644 1/20 0.33
GABRA3 P34903 1/20 0.33
GABRA2 P47869 1/20 0.33
GABRA6 Q16445 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7305966 0.86 PDE3B (0.57) PDE3BPDE3AKDM4EBACE1HMGCR
SCHEMBL7311043 0.80 PDE3B (0.50) PDE3BPDE3AKDM4EBACE1HMGCR
SCHEMBL7315407 0.76 PDE3B (0.46) PDE3BPDE3AKDM4EBACE1TSHR
SCHEMBL7313861 0.74 PDE3B (0.44) PDE3BPDE3AKDM4ETNFPDE10A
SCHEMBL7317446 0.74 TP53 (0.44) PDE3BPDE3AKDM4EPDE10A
SCHEMBL7309250 0.72 PDE3B (0.44) PDE3BPDE3AKDM4EHMGCRTSHR
SCHEMBL7319613 0.69 ALDH1A1 (0.41) PDE3BPDE3AKDM4ETSHR
SCHEMBL7307941 0.69 PDE3B (0.35) PDE3BPDE3AKDM4ETNF
SCHEMBL13183946 0.68 TSHR (0.41) PDE3BPDE3AKDM4EEGFRSRC
SCHEMBL22307576 0.66 TSHR (0.43) PDE3BPDE3AKDM4EEGFRSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4822800-A Isoquinolinol compounds having cardiotonic and phosphodiesterase fraction III inhibiting properties and/or renal vasodilating properties ORTHO PHARMACEUTICAL CORPORATION (US) 1989-04-18 US disclosed